Endocrinology

Science at Genzyme Research Areas Technology Platforms Pipeline Clinical Trials Research Grants Investigator-Sponsored Studies Animals in Research Research Publications

All Publications

Borget I, Corone C, Nocaudie M, Allyn M, Iacobelli S, Schlumberger M, De Pouvourville G. 2007. Sick leave for follow-up control in thyroid cancer patients: Comparison between stimulation with Thyrogen and thyroid hormone withdrawal. Eu J Endocrin 156(5):531-8.
Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis M, Maxon HR, Sherman SI. 2006. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid. 16:1229-1242.
Robbins RJ, Driedger A, Magner J. 2006. Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine. Thyroid 16:1121-1130.
Magner JA. 2004. Thyroid-stimulating hormone-mediated hyperthyroidism. Endocrinologist 14:201-211.

Genzyme Partnering

49 New York Avenue
Framingham, MA 01701
USA

Send email

EU Partnering

Gooimeer 10
1411 DD NAARDEN
The Netherlands
F: +31 35 699 1400

Send email

Free Drug Programs

Find out how Genzyme provides free treatment to patients in need by working with local governments, humanitarian groups, and others.

Targeting Unmet Needs

View our specialized portfolio of therapies, which provide personalized treatment for patients with rare diseases.

Latest Press Releases

Keep up to date by reading the latest press releases for Genzyme.

Jobs at Genzyme

Explore exciting opportunities in research, development, and all other aspects of biotechnology.

infoBox